Cracking the Code: Musculoskeletal Must-Knows for Your FNP Boards
Musculoskeletal · 3 min read · July 21, 2026
Cracking the Code: Musculoskeletal Must-Knows for Your FNP Boards
Hey future FNPs! Feeling overwhelmed by the sheer volume of information for your board exams? The musculoskeletal system might seem daunting, but with a focused approach, you can master the high-yield concepts and walk into your exam with confidence. Musculoskeletal conditions are a consistent presence on the FNP boards, so let's break down what you absolutely need to know.
Differentiating Common Arthropathies: OA, RA, and Gout
Understanding the nuances between Osteoarthritis (OA), Rheumatoid Arthritis (RA), and Gout is crucial. These conditions often present with similar symptoms, but their underlying pathophysiology, typical presentation, and treatment approaches are distinct and frequently tested.
Osteoarthritis (OA): The Wear-and-Tear Arthritis
- Pathophysiology: OA is a non-inflammatory, degenerative joint disorder caused by the breakdown of articular cartilage, leading to bone-on-bone contact.
- Presentation: Patients typically experience pain that worsens with activity and improves with rest. Morning stiffness is usually less than 30 minutes. Look for Heberden's nodes (DIP joints) and Bouchard's nodes (PIP joints), and crepitus. Pain is often asymmetrical and affects weight-bearing joints like knees, hips, and the spine.
- Diagnosis: Primarily clinical, supported by X-rays showing joint space narrowing, osteophytes, and subchondral sclerosis.
- Treatment: Focus on non-pharmacologic measures like exercise, weight loss, and physical therapy. Pharmacologic options include topical NSAIDs (first-line for knee OA), oral NSAIDs, acetaminophen, and intra-articular corticosteroids for flares. Duloxetine is FDA-approved for chronic musculoskeletal pain.
Rheumatoid Arthritis (RA): The Autoimmune Attacker
- Pathophysiology: RA is a chronic, inflammatory autoimmune disorder where the body's immune system attacks the synovial membrane, leading to joint destruction.
- Presentation: Characterized by symmetrical polyarthritis, commonly affecting the MCP and PIP joints (sparing the DIPs). Morning stiffness lasts longer than one hour. Patients may report systemic symptoms like fatigue and fever, and extra-articular manifestations such as rheumatoid nodules.
- Diagnosis: Clinical presentation combined with laboratory findings such as elevated RF and anti-CCP antibody (more specific than RF). X-rays may show periarticular osteopenia, joint space narrowing, and erosions.
- Treatment: DMARDs (Disease-Modifying Antirheumatic Drugs) are the cornerstone, with methotrexate often being first-line. Biologics are used for inadequate response. NSAIDs and glucocorticoids manage symptoms but do not modify the disease course.
Gout: The Crystal Culprit
- Pathophysiology: Gout is caused by the deposition of uric acid crystals in joints, triggering acute inflammatory arthritis.
- Presentation: Sudden onset of severe joint pain, swelling, and erythema, most commonly in the first metatarsophalangeal (MTP) joint (podagra). Triggers include alcohol (especially beer), red meat, shellfish, diuretics, and dehydration.
- Diagnosis: Clinical suspicion, elevated serum uric acid (though it can be normal during an acute attack), and definitive diagnosis via arthrocentesis showing negatively birefringent, needle-shaped uric acid crystals.
- Treatment: Acute attacks are managed with NSAIDs, colchicine, or corticosteroids. Long-term management involves urate-lowering therapy like allopurinol to prevent future attacks.
Clinical Pearl: Remember that pseudogout is also a crystalline arthropathy but is caused by calcium pyrophosphate dihydrate (CPPD) crystals, often affecting larger joints like the knee. While symptoms can be similar to gout, pseudogout crystals are rhomboid-shaped and positively birefringent.
Red Flags in Musculoskeletal Pain: Don't Miss Them!
Identifying